PubMed · 2016 · 17 citations · 12 references
MedicineDermatologyPharmacotherapyAllergyHypersensitivityPhotodermatologyInflammatory Skin DiseasesInflammatory Skin DisordersOphthalmic GelsSkin CareSkin SafetyAcne PharmacotherapyDapsone TherapyLocal Tissue TolerabilityLocal Tolerability AssessmentMulticenter Clinical TrialsPercentage Change AnalysisTherapy TolerabilityTreatment With Topical Corticosteroids
Dapsone gel, 7.5%, with a 50-percent greater dapsone concentration than twice-daily dapsone gel, 5% formulation, is applied topically once daily for acne, is effective, safe, and well-tolerated over 12 weeks, and has local tolerability similar to that of vehicle. www.clinicaltrials.gov identifiers: NCT01974141 and NCT01974323.
12